Lexington Biosciences, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
Lexington Biosciences, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced net loss was CAD 45,210 compared to CAD 101,025 a year ago. Basic eps - continuing operations was CAD 0 compared to CAD 0.03 a year ago. For the nine months, net loss was CAD 389,801 compared to CAD 431,350 a year ago. Basic earnings per share from continuing operations was CAD 0.06 compared to CAD 0.11 a year ago.